Prophase Labs is Pharmaceuticals in United States that focus on ProPhase Labs Inc business. Founded in 1989. They cover business area such as ProPhase Labs Inc, distributor, homeopathic and health product, development, manufacture, distribution, marketing, sale, the-counter, dietary supplement, its product, tk supplement, Legendz XL, Triple Edge XL, Super ProstaFlow, prostate, urinary health, diagnostic service, consumer product, maximum revenue.
1989
( 35 years old in 2024 )
ProPhase Labs Inc
-
P. O. Box 1349
Doylestown, PA 18901
United States
Private
ProPhase Labs Incdistributorhomeopathic and health productdevelopmentmanufacturedistributionmarketingsalethe-counterdietary supplementits producttk supplementLegendz XLTriple Edge XLSuper ProstaFlowprostateurinary healthdiagnostic serviceconsumer productmaximum revenue
* We use standard office opening hours in near Prophase Labs's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Prophase Labs is Pharmaceuticals business from United States that founded in 1989 (35 years old in 2024), Prophase Labs business is focusing on ProPhase Labs Inc.
Prophase Labs headquarter office and corporate office address is located in P. O. Box 1349 Doylestown, PA 18901 United States.
Prophase Labs was founded in United States.
In 2024, Prophase Labs is currently focus on ProPhase Labs Inc sector.
Above is snippet of Google Trends for "ProPhase Labs Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Prophase Labs, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
